tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

NervGen Pharma to Present at Virtual Life Sciences Investor Forum
Company AnnouncementsNervGen Pharma to Present at Virtual Life Sciences Investor Forum
7h ago
NervGen Pharma Aligns Employee Incentives with Stock Options Grant
PremiumCompany Announcements
NervGen Pharma Aligns Employee Incentives with Stock Options Grant
15d ago
NervGen Pharma Advances NVG-291 Clinical Trial for Spinal Cord Injury
PremiumCompany Announcements
NervGen Pharma Advances NVG-291 Clinical Trial for Spinal Cord Injury
27d ago
NervGen Pharma to Showcase Innovative Neurorestorative Therapies at Oppenheimer Conference
PremiumCompany Announcements
NervGen Pharma to Showcase Innovative Neurorestorative Therapies at Oppenheimer Conference
1M ago
NervGen Pharma price target raised to C$4.50 from C$3 at Raymond James
PremiumThe Fly
NervGen Pharma price target raised to C$4.50 from C$3 at Raymond James
2M ago
NervGen upgraded to Outperform from Market Perform at Raymond James
PremiumThe FlyNervGen upgraded to Outperform from Market Perform at Raymond James
2M ago
NervGen Pharma Advances Clinical Trials for Spinal Cord Injury
Premium
Company Announcements
NervGen Pharma Advances Clinical Trials for Spinal Cord Injury
2M ago
NervGen Pharma Launches Equity Program for Flexibility
Premium
Company Announcements
NervGen Pharma Launches Equity Program for Flexibility
3M ago
NervGen Pharma Nears Trial Enrollment Completion
PremiumCompany Announcements
NervGen Pharma Nears Trial Enrollment Completion
4M ago
NervGen Pharma to Present Innovative Treatments
PremiumCompany Announcements
NervGen Pharma to Present Innovative Treatments
4M ago
NervGen Pharma Advances Spinal Injury Treatment Trial
PremiumCompany Announcements
NervGen Pharma Advances Spinal Injury Treatment Trial
5M ago
NervGen Pharma Spotlights Spinal Injury Treatment
PremiumCompany Announcements
NervGen Pharma Spotlights Spinal Injury Treatment
6M ago
NervGen Pharma Highlights SCI Treatment Advances
PremiumCompany AnnouncementsNervGen Pharma Highlights SCI Treatment Advances
6M ago
NervGen Pharma to Present at Global Investment Conference
Premium
Company Announcements
NervGen Pharma to Present at Global Investment Conference
6M ago
NervGen Pharma Excels in Clinical Trials and Drug Development
Premium
Company Announcements
NervGen Pharma Excels in Clinical Trials and Drug Development
7M ago
NervGen Pharma Showcases at Major Growth Conference
PremiumCompany Announcements
NervGen Pharma Showcases at Major Growth Conference
7M ago
NervGen Pharma Issues New Stock Options
PremiumCompany Announcements
NervGen Pharma Issues New Stock Options
7M ago
NervGen Pharma Strengthens Board for Clinical Advancements
PremiumCompany Announcements
NervGen Pharma Strengthens Board for Clinical Advancements
8M ago
NervGen Pharma initiated with a Market Perform at Raymond James
PremiumThe Fly
NervGen Pharma initiated with a Market Perform at Raymond James
8M ago
NervGen Pharma Advances NVG-300 for Neurological Disorders
PremiumCompany AnnouncementsNervGen Pharma Advances NVG-300 for Neurological Disorders
8M ago
NervGen Pharma Updates at SCI Investor Symposium
Premium
Company Announcements
NervGen Pharma Updates at SCI Investor Symposium
9M ago
NervGen Pharma Unveils New Stock Options Plan
Premium
Company Announcements
NervGen Pharma Unveils New Stock Options Plan
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >